ruboxistaurin has been researched along with 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide in 1 studies
| Studies (ruboxistaurin) | Trials (ruboxistaurin) | Recent Studies (post-2010) (ruboxistaurin) | Studies (2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide) | Trials (2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide) | Recent Studies (post-2010) (2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide) |
|---|---|---|---|---|---|
| 203 | 29 | 56 | 19 | 0 | 6 |
| Protein | Taxonomy | ruboxistaurin (IC50) | 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide (IC50) |
|---|---|---|---|
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.013 | |
| Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Oryctolagus cuniculus (rabbit) | 0.75 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | 2 | |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | 1.89 | |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 8.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Bain, J; Deak, M; Elliott, M; Garrido-Franco, M; Komander, D; Kozikowski, AP; Kular, GS; Prakash, KR; Schüttelkopf, AW; van Aalten, DM | 1 |
1 other study(ies) available for ruboxistaurin and 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide
| Article | Year |
|---|---|
Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Indoles; Maleimides; Models, Molecular; Protein Kinase C; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Signal Transduction | 2004 |